Episode Archive
308 episodes of Oncology Today with Dr Neil Love since the first episode, which aired on April 9th, 2020.
-
Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer
May 3rd, 2024 | Season 1 | 59 mins 39 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the optimal management of gastroesophageal cancer with Prof Eric Van Cutsem, moderated by Dr Neil Love. Produced by Research To Practice.
-
Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series
May 1st, 2024 | Season 1 | 1 hr 47 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the optimal management of myelofibrosis with Dr Ruben A Mesa, moderated by Dr Neil Love. Produced by Research To Practice.
-
Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria
April 26th, 2024 | Season 1 | 1 hr 37 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on paroxysmal nocturnal hemoglobinuria, with Dr Carlos de Castro, Prof Alexander Röth and Dr Ilene Weitz, moderated by Dr Neil Love. Produced by Research To Practice.
-
Special Edition – Prostate Cancer Updates from a CME Program Held at the 2024 Genitourinary Cancers Symposium
April 24th, 2024 | Season 1 | 59 mins 51 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring an overview of recent clinical data presented at the 2024 Genitourinary Cancers Symposium with Dr Emmanuel Antonarakis, moderated by Dr Neil Love. Produced by Research To Practice.
-
Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences
April 23rd, 2024 | Season 1 | 1 hr 4 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring presentations from the 2023 ASH annual meeting on the management of myelofibrosis and other myeloproliferative neoplasms moderated by Dr Neil Love. Produced by Research To Practice.
-
Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition
April 15th, 2024 | Season 1 | 37 mins 19 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the role of HER2-directed therapy in the treatment of gastrointestinal tumors, moderated by Dr Neil Love. Produced by Research To Practice.
-
Key Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences
April 12th, 2024 | Season 1 | 1 hr 35 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring updates for the management of CLL and Richter’s transformation from ASH 2023 with Dr Bita Fakhri, moderated by Dr Neil Love. Produced by Research To Practice
-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer
April 5th, 2024 | Season 1 | 58 mins 42 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the optimal management of colorectal cancer with Professor Thierry André and Dr Arvind Dasari, moderated by Dr Neil Love. Produced by Research To Practice.
-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Urothelial Bladder Cancer
April 5th, 2024 | Season 1 | 1 hr 56 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the management of urothelial bladder cancer with Dr Shilpa Gupta and Prof Thomas Powles, moderated by Dr Neil Love. Produced by Research To Practice.
-
The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates
April 3rd, 2024 | Season 1 | 1 hr 14 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on early research and available data with B7-H3-targeted antibody-drug conjugates with Dr Manish Patel, moderated by Dr Neil Love. Produced by Research To Practice.
-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer
March 27th, 2024 | Season 1 | 1 hr 1 min
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on clinical data from the past year on the management of prostate cancer with Drs Andrew Armstrong and Maha Hussain, moderated by Dr Neil Love. Produced by Research To Practice.
-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma
March 26th, 2024 | Season 1 | 1 hr 13 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the management of lymphoma with Dr Andrew M Evens and Dr Sonali M Smith, moderated by Dr Neil Love. Produced by Research To Practice.
-
Overcoming Endocrine Resistance in ER-Positive Metastatic Breast Cancer
March 25th, 2024 | Season 1 | 1 hr 19 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Dr Seth Wander from Harvard Medical School in Boston, Massachusetts, discusses mechanisms underlying endocrine resistance in breast cancer and optimal therapeutic approaches for patients who experience disease progression while or after receiving endocrine therapy.
-
Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review
March 21st, 2024 | Season 1 | 1 hr 1 min
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the management of hepatobiliary cancers with Dr Robin K (Katie) Kelley and Dr Mark Yarchoan, moderated by Dr Neil Love. Produced by Research To Practice.
-
Promising Therapeutic Strategies for Patients with Progressive Metastatic Non-Small Cell Lung Cancer
March 19th, 2024 | Season 1 | 1 hr 2 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the role of approved and investigational antibody drug conjugates for non-small cell lung cancer, moderated by Dr Neil Love. Produced by Research To Practice.
-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer
March 15th, 2024 | Season 1 | 1 hr 5 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the management of HER2-positive and triple-negative breast cancer with Dr Ian E Krop and Dr Priyanka Sharma, moderated by Dr Neil Love. Produced by Research To Practice.